Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Epigenetic drug therapy in the treatment of colorectal cancer.

Parizadeh SM, Esfehani RJ, Ghandehari M, Seifi S, Parizadeh SMR, Moetamani-Ahmadi M, Hassanian SM, Khazaei M, Ferns GA, Ghayour-Mobarhan M, Avan A.

Curr Pharm Des. 2018 Jul 30. doi: 10.2174/1381612824666180730151904. [Epub ahead of print]

PMID:
30062956
2.

Pharmacogenetics of anticancer drug sensitivity and toxicity in colorectal cancer.

Moradi-Marjaneh R, Khazaei M, Seifi S, Hassanian SM, Ferns GA, Avan A.

Curr Pharm Des. 2018 Jul 27. doi: 10.2174/1381612824666180727144535. [Epub ahead of print]

PMID:
30051785
3.

The diagnostic and prognostic value of copeptin in cardiovascular disease, current status, and prospective.

Parizadeh SM, Ghandehari M, Parizadeh MR, Ferns GA, Ghayour-Mobarhan M, Avan A, Hassanian SM.

J Cell Biochem. 2018 Jul 16. doi: 10.1002/jcb.27093. [Epub ahead of print] Review.

PMID:
30011137
4.

Role of adenosine signaling in the pathogenesis of head and neck cancer.

Khayami R, Toroghian Y, Bahreyni A, Bahrami A, Khazaei M, Ferns GA, Ebrahimi S, Soleimani A, Fiuji H, Avan A, Hassanian SM.

J Cell Biochem. 2018 Jul 16. doi: 10.1002/jcb.27091. [Epub ahead of print] Review.

PMID:
30011093
5.

Toll-like receptors signaling pathways as a potential therapeutic target in cardiovascular disease.

Parizadeh SM, Ghandehari M, Heydari-Majd M, Seifi S, Mardani R, Parizadeh SM, Ghayour-Mobarhan M, Ferns GA, Hassanian SM, Avan A.

Curr Pharm Des. 2018 Jun 13. doi: 10.2174/1381612824666180614090224. [Epub ahead of print]

PMID:
29898648
6.

Crocus sativus a natural food coloring and flavoring has potent anti-tumor properties.

Khorasanchi Z, Shafiee M, Kermanshahi F, Khazaei M, Ryzhikov M, Parizadeh MR, Kermanshahi B, Ferns GA, Avan A, Hassanian SM.

Phytomedicine. 2018 Apr 1;43:21-27. doi: 10.1016/j.phymed.2018.03.041. Epub 2018 Mar 19. Review.

PMID:
29747750
7.

Targeting the death receptor signaling pathway as a potential therapeutic target in the treatment of colorectal cancer.

Moradi Marjaneh R, Hassanian SM, Ghobadi N, Ferns GA, Karimi A, Jazayeri MH, Nasiri M, Avan A, Khazaei M.

J Cell Physiol. 2018 Oct;233(10):6538-6549. doi: 10.1002/jcp.26640. Epub 2018 May 9. Review.

PMID:
29741789
8.

Phytosomal curcumin inhibits tumor growth in colitis-associated colorectal cancer.

Marjaneh RM, Rahmani F, Hassanian SM, Rezaei N, Hashemzehi M, Bahrami A, Ariakia F, Fiuji H, Sahebkar A, Avan A, Khazaei M.

J Cell Physiol. 2018 Oct;233(10):6785-6798. doi: 10.1002/jcp.26538. Epub 2018 May 8.

PMID:
29737515
9.

A genetic polymorphism in the CYP1B1 gene in patients with squamous cell carcinoma of the esophagus: an Iranian Mashhad cohort study recruited over 10 years.

Moghadam AR, Mehramiz M, Entezari M, Aboutalebi H, Kohansal F, Dadjoo P, Fiuji H, Nasiri M, Aledavood SA, Anvari K, Simab SA, Khorrami MS, Moradi A, Hassanian SM, Ferns GA, Sales SS, Avan A.

Pharmacogenomics. 2018 Apr;19(6):539-546. doi: 10.2217/pgs-2018-0197. Epub 2018 Apr 9.

PMID:
29629838
10.

The 9p21 locus as a potential therapeutic target and prognostic marker in colorectal cancer.

Bahrami A, Hassanian SM, Khazaei M, Gharib M, Rahmani M, Fiuji H, Jazayeri MH, Moetamani-Ahmadi M, Ferns GA, Avan A.

Pharmacogenomics. 2018 Apr;19(5):463-474. doi: 10.2217/pgs-2017-0096. Epub 2018 Apr 9.

PMID:
29629612
11.

Phytosomal-curcumin antagonizes cell growth and migration, induced by thrombin through AMP-Kinase in breast cancer.

Hashemzehi M, Behnam-Rassouli R, Hassanian SM, Moradi-Binabaj M, Moradi-Marjaneh R, Rahmani F, Fiuji H, Jamili M, Mirahmadi M, Boromand N, Piran M, Jafari M, Sahebkar A, Avan A, Khazaei M.

J Cell Biochem. 2018 Jul;119(7):5996-6007. doi: 10.1002/jcb.26796. Epub 2018 Mar 30.

PMID:
29600521
12.

The 9p21 locus: A potential therapeutic target and prognostic marker in breast cancer.

Rivandi M, Khorrami MS, Fiuji H, Shahidsales S, Hasanzadeh M, Jazayeri MH, Hassanian SM, Ferns GA, Saghafi N, Avan A.

J Cell Physiol. 2018 Jul;233(7):5170-5179. doi: 10.1002/jcp.26332. Epub 2018 Jan 23. Review.

PMID:
29240242
13.

Current status and future prospective of Curcumin as a potential therapeutic agent in the treatment of colorectal cancer.

Jalili-Nik M, Soltani A, Moussavi S, Ghayour-Mobarhan M, Ferns GA, Hassanian SM, Avan A.

J Cell Physiol. 2018 Sep;233(9):6337-6345. doi: 10.1002/jcp.26368. Epub 2018 Mar 14. Review.

PMID:
29219177
14.

The diagnostic and prognostic value of circulating microRNAs in coronary artery disease: A novel approach to disease diagnosis of stable CAD and acute coronary syndrome.

Parizadeh SM, Ferns GA, Ghandehari M, Hassanian SM, Ghayour-Mobarhan M, Parizadeh SMR, Avan A.

J Cell Physiol. 2018 Sep;233(9):6418-6424. doi: 10.1002/jcp.26324. Epub 2018 Mar 14. Review.

PMID:
29215707
15.

Therapeutic potency of mTOR signaling pharmacological inhibitors in the treatment of proinflammatory diseases, current status, and perspectives.

Soltani A, Bahreyni A, Boroumand N, Roshan MK, Khazaei M, Ryzhikov M, Soleimanpour S, Avan A, Hassanian SM.

J Cell Physiol. 2018 Jun;233(6):4783-4790. doi: 10.1002/jcp.26276. Epub 2017 Dec 26.

PMID:
29165795
16.

Toll like receptor signaling pathway as a potential therapeutic target in colorectal cancer.

Moradi-Marjaneh R, Hassanian SM, Fiuji H, Soleimanpour S, Ferns GA, Avan A, Khazaei M.

J Cell Physiol. 2018 Aug;233(8):5613-5622. doi: 10.1002/jcp.26273. Epub 2018 Mar 1. Review.

PMID:
29150944
17.

The current status and perspectives regarding the clinical implication of intracellular calcium in breast cancer.

Tajbakhsh A, Pasdar A, Rezaee M, Fazeli M, Soleimanpour S, Hassanian SM, FarshchiyanYazdi Z, Younesi Rad T, Ferns GA, Avan A.

J Cell Physiol. 2018 Aug;233(8):5623-5641. doi: 10.1002/jcp.26277. Epub 2018 Feb 28. Review.

PMID:
29150934
18.

Saffron against Components of Metabolic Syndrome: Current Status and Prospective.

Shafiee M, Aghili Moghaddam NS, Nosrati M, Tousi M, Avan A, Ryzhikov M, Parizadeh MR, Fiuji H, Rajabian M, Bahreyni A, Khazaei M, Hassanian SM.

J Agric Food Chem. 2017 Dec 20;65(50):10837-10843. doi: 10.1021/acs.jafc.7b03762. Epub 2017 Dec 8. Review.

PMID:
29136374
19.

The interaction between a HSP-70 gene variant with dietary calories in determining serum markers of inflammation and cardiovascular risk.

Mehramiz M, Hassanian SM, Mardan-Nik M, Pasdar A, Jamialahmadi K, Fiuji H, Moetamani-Ahmadi M, Parizadeh SMR, Moohebati M, Heidari-Bakavoli A, Ebrahimi M, Ferns GA, Ghayour-Mobarhan M, Avan A.

Clin Nutr. 2017 Oct 24. pii: S0261-5614(17)31366-3. doi: 10.1016/j.clnu.2017.10.006. [Epub ahead of print]

PMID:
29128340
20.

Clinical and prognostic value of the C-Met/HGF signaling pathway in cervical cancer.

Boromand N, Hasanzadeh M, ShahidSales S, Farazestanian M, Gharib M, Fiuji H, Behboodi N, Ghobadi N, Hassanian SM, Ferns GA, Avan A.

J Cell Physiol. 2018 Jun;233(6):4490-4496. doi: 10.1002/jcp.26232. Epub 2017 Nov 24. Review.

PMID:
29058790
21.

Therapeutic potency of pharmacological adenosine receptor agonist/antagonist in angiogenesis, current status and perspectives.

Bahreyni A, Khazaei M, Rajabian M, Ryzhikov M, Avan A, Hassanian SM.

J Pharm Pharmacol. 2018 Feb;70(2):191-196. doi: 10.1111/jphp.12844. Epub 2017 Oct 23. Review.

PMID:
29057476
22.

Therapeutic potency of heat-shock protein-90 pharmacological inhibitors in the treatment of gastrointestinal cancer, current status and perspectives.

Boroumand N, Saghi H, Avan A, Bahreyni A, Ryzhikov M, Khazaei M, Hassanian SM.

J Pharm Pharmacol. 2018 Feb;70(2):151-158. doi: 10.1111/jphp.12824. Epub 2017 Oct 4. Review.

PMID:
28980313
23.

Depression and anxiety symptoms are associated with white blood cell count and red cell distribution width: A sex-stratified analysis in a population-based study.

Shafiee M, Tayefi M, Hassanian SM, Ghaneifar Z, Parizadeh MR, Avan A, Rahmani F, Khorasanchi Z, Azarpajouh MR, Safarian H, Moohebati M, Heidari-Bakavoli A, Esmaeili H, Nematy M, Safarian M, Ebrahimi M, Ferns GA, Mokhber N, Ghayour-Mobarhan M.

Psychoneuroendocrinology. 2017 Oct;84:101-108. doi: 10.1016/j.psyneuen.2017.06.021. Epub 2017 Jul 3.

PMID:
28697416
24.

Genetic variation in the DNA repair pathway as a potential determinant of response to platinum-based chemotherapy in breast cancer.

Beheshti F, Hassanian SM, Khazaei M, Hosseini M, ShahidSales S, Hasanzadeh M, Maftouh M, Ferns GA, Avan A.

J Cell Physiol. 2018 Apr;233(4):2752-2758. doi: 10.1002/jcp.26091. Epub 2017 Aug 30. Review.

PMID:
28696006
25.

Therapeutic potentials of adenosine receptors agonists and antagonists in colitis; Current status and perspectives.

Bahreyni A, Samani SS, Khazaei M, Ryzhikov M, Avan A, Hassanian SM.

J Cell Physiol. 2018 Apr;233(4):2733-2740. doi: 10.1002/jcp.26073. Epub 2017 Aug 3. Review.

PMID:
28661026
26.

Adenosine: An endogenous mediator in the pathogenesis of gynecological cancer.

Bahreyni A, Samani SS, Ghorbani E, Rahmani F, Khayami R, Toroghian Y, Behnam-Rassouli R, Khazaei M, Ryzhikov M, Parizadeh MR, Hasanzadeh M, Avan A, Hassanian SM.

J Cell Physiol. 2018 Apr;233(4):2715-2722. doi: 10.1002/jcp.26056. Epub 2017 Sep 8. Review.

PMID:
28617999
27.

The Therapeutic Potential of Targeting Tumor Microenvironment in Breast Cancer: Rational Strategies and Recent Progress.

Bahrami A, Hassanian SM, Khazaei M, Hasanzadeh M, Shahidsales S, Maftouh M, Ferns GA, Avan A.

J Cell Biochem. 2018 Jan;119(1):111-122. doi: 10.1002/jcb.26183. Epub 2017 Jul 4. Review.

PMID:
28574616
28.

Targeting the tumor microenvironment as a potential therapeutic approach in colorectal cancer: Rational and progress.

Bahrami A, Khazaei M, Hassanian SM, ShahidSales S, Joudi-Mashhad M, Maftouh M, Jazayeri MH, Parizade MR, Ferns GA, Avan A.

J Cell Physiol. 2018 Apr;233(4):2928-2936. doi: 10.1002/jcp.26041. Epub 2017 Jun 30. Review.

PMID:
28574572
29.

Genetic Background of Hirschsprung Disease: A Bridge Between Basic Science and Clinical Application.

Bahrami A, Joodi M, Moetamani-Ahmadi M, Maftouh M, Hassanian SM, Ferns GA, Avan A.

J Cell Biochem. 2018 Jan;119(1):28-33. doi: 10.1002/jcb.26149. Epub 2017 Jun 27. Review.

PMID:
28543993
30.

Genetic susceptibility in cervical cancer: From bench to bedside.

Bahrami A, Hasanzadeh M, Shahidsales S, Farazestanian M, Hassanian SM, Moetamani Ahmadi M, Maftouh M, Gharib M, Yousefi Z, Kadkhodayan S, Ferns GA, Avan A.

J Cell Physiol. 2018 Mar;233(3):1929-1939. doi: 10.1002/jcp.26019. Epub 2017 Sep 7. Review.

PMID:
28542881
31.

The genetic factors contributing to the development of Wilm's tumor and their clinical utility in its diagnosis and prognosis.

Bahrami A, Joodi M, Maftooh M, Ferns GA, M Ahmadi M, Hassanian SM, Avan A.

J Cell Physiol. 2018 Apr;233(4):2882-2888. doi: 10.1002/jcp.26021. Epub 2017 Jul 4. Review.

PMID:
28542793
32.

The Therapeutic Potential of PI3K/Akt/mTOR Inhibitors in Breast Cancer: Rational and Progress.

Bahrami A, Khazaei M, Shahidsales S, Hassanian SM, Hasanzadeh M, Maftouh M, Ferns GA, Avan A.

J Cell Biochem. 2018 Jan;119(1):213-222. doi: 10.1002/jcb.26136. Epub 2017 Jul 4. Review.

PMID:
28513879
33.

The Potential Value of the PI3K/Akt/mTOR Signaling Pathway for Assessing Prognosis in Cervical Cancer and as a Target for Therapy.

Bahrami A, Hasanzadeh M, Hassanian SM, ShahidSales S, Ghayour-Mobarhan M, Ferns GA, Avan A.

J Cell Biochem. 2017 Dec;118(12):4163-4169. doi: 10.1002/jcb.26118. Epub 2017 Jun 22. Review.

PMID:
28475243
34.

Genetic variants as potential predictive biomarkers in advanced colorectal cancer patients treated with oxaliplatin-based chemotherapy.

Bahrami A, Amerizadeh F, Hassanian SM, ShahidSales S, Khazaei M, Maftouh M, Ghayour-Mobarhan M, Ferns GA, Avan A.

J Cell Physiol. 2018 Mar;233(3):2193-2201. doi: 10.1002/jcp.25966. Epub 2017 May 23. Review.

PMID:
28422287
35.

Therapeutic potential of novel formulated forms of curcumin in the treatment of breast cancer by the targeting of cellular and physiological dysregulated pathways.

Tajbakhsh A, Hasanzadeh M, Rezaee M, Khedri M, Khazaei M, ShahidSales S, Ferns GA, Hassanian SM, Avan A.

J Cell Physiol. 2018 Mar;233(3):2183-2192. doi: 10.1002/jcp.25961. Epub 2017 May 23. Review.

PMID:
28419458
36.

The therapeutic potential of targeting the BRAF mutation in patients with colorectal cancer.

Bahrami A, Hesari A, Khazaei M, Hassanian SM, Ferns GA, Avan A.

J Cell Physiol. 2018 Mar;233(3):2162-2169. doi: 10.1002/jcp.25952. Epub 2017 May 23. Review.

PMID:
28407239
37.

Role of adenosine signaling in the pathogenesis of breast cancer.

Bahreyni A, Samani SS, Rahmani F, Behnam-Rassouli R, Khazaei M, Ryzhikov M, Parizadeh MR, Avan A, Hassanian SM.

J Cell Physiol. 2018 Mar;233(3):1836-1843. doi: 10.1002/jcp.25944. Epub 2017 May 23. Review.

PMID:
28383816
38.

A genetic variant in CDKN2A/B gene is associated with the increased risk of breast cancer.

ShahidSales S, Mehramiz M, Ghasemi F, Aledavood A, Shamsi M, Hassanian SM, Ghayour-Mobarhan M, Avan A.

J Clin Lab Anal. 2018 Jan;32(1). doi: 10.1002/jcla.22190. Epub 2017 Mar 9.

PMID:
28276595
39.

The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials.

Binabaj MM, Bahrami A, ShahidSales S, Joodi M, Joudi Mashhad M, Hassanian SM, Anvari K, Avan A.

J Cell Physiol. 2018 Jan;233(1):378-386. doi: 10.1002/jcp.25896. Epub 2017 May 16. Review.

PMID:
28266716
40.

Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer.

Rahmani F, Avan A, Hashemy SI, Hassanian SM.

J Cell Physiol. 2018 Feb;233(2):811-817. doi: 10.1002/jcp.25897. Epub 2017 May 3. Review.

PMID:
28266708
41.

Targeting RAS signaling pathway as a potential therapeutic target in the treatment of colorectal cancer.

Bahrami A, Hassanian SM, ShahidSales S, Farjami Z, Hasanzadeh M, Anvari K, Aledavood A, Maftouh M, Ferns GA, Khazaei M, Avan A.

J Cell Physiol. 2018 Mar;233(3):2058-2066. doi: 10.1002/jcp.25890. Epub 2017 May 23. Review.

PMID:
28262927
42.

Relationship between serum anti-heat shock protein 27 antibody levels and obesity.

Kargari M, Tavassoli S, Avan A, Ebrahimi M, Azarpazhooh MR, Asoodeh R, Nematy M, Hassanian SM, Rahmani F, Mohammadzade E, Esmaeili H, Moohebati M, Ferns GA, Ghayour-Mobarhan M, Parizadeh SMR.

Clin Biochem. 2017 Aug;50(12):690-695. doi: 10.1016/j.clinbiochem.2017.02.015. Epub 2017 Feb 22.

PMID:
28237841
43.

Therapeutic Potentials of BDNF/TrkB in Breast Cancer; Current Status and Perspectives.

Tajbakhsh A, Mokhtari-Zaer A, Rezaee M, Afzaljavan F, Rivandi M, Hassanian SM, Ferns GA, Pasdar A, Avan A.

J Cell Biochem. 2017 Sep;118(9):2502-2515. doi: 10.1002/jcb.25943. Epub 2017 May 15. Review.

PMID:
28230291
44.

Therapeutic Potential of Targeting PI3K/AKT Pathway in Treatment of Colorectal Cancer: Rational and Progress.

Bahrami A, Khazaei M, Hasanzadeh M, ShahidSales S, Joudi Mashhad M, Farazestanian M, Sadeghnia HR, Rezayi M, Maftouh M, Hassanian SM, Avan A.

J Cell Biochem. 2018 Mar;119(3):2460-2469. doi: 10.1002/jcb.25950. Epub 2017 May 15.

PMID:
28230287
45.

Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer.

Ebrahimi S, Hosseini M, Shahidsales S, Maftouh M, Ferns GA, Ghayour-Mobarhan M, Hassanian SM, Avan A.

Curr Med Chem. 2017;24(13):1321-1331. doi: 10.2174/0929867324666170206142658. Review.

PMID:
28176634
46.

GD2-targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma.

Gholamin S, Mirzaei H, Razavi SM, Hassanian SM, Saadatpour L, Masoudifar A, ShahidSales S, Avan A.

J Cell Physiol. 2018 Feb;233(2):866-879. doi: 10.1002/jcp.25793. Epub 2017 May 23. Review.

PMID:
28145567
47.

Interferon-Mediated Tumor Resistance to Oncolytic Virotherapy.

Ebrahimi S, Ghorbani E, Khazaei M, Avan A, Ryzhikov M, Azadmanesh K, Hassanian SM.

J Cell Biochem. 2017 Aug;118(8):1994-1999. doi: 10.1002/jcb.25917. Epub 2017 Apr 25. Review.

PMID:
28135008
48.

Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress.

Bahrami A, Amerizadeh F, ShahidSales S, Khazaei M, Ghayour-Mobarhan M, Sadeghnia HR, Maftouh M, Hassanian SM, Avan A.

J Cell Biochem. 2017 Aug;118(8):1979-1983. doi: 10.1002/jcb.25903. Epub 2017 Apr 25. Review.

PMID:
28109136
49.

The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.

Bahrami A, Aledavood A, Anvari K, Hassanian SM, Maftouh M, Yaghobzade A, Salarzaee O, ShahidSales S, Avan A.

J Cell Physiol. 2018 Feb;233(2):774-786. doi: 10.1002/jcp.25813. Epub 2017 Mar 24. Review.

PMID:
28109133
50.

Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives.

Hosseini M, Hassanian SM, Mohammadzadeh E, ShahidSales S, Maftouh M, Fayazbakhsh H, Khazaei M, Avan A.

J Cell Biochem. 2017 Jul;118(7):1634-1638. doi: 10.1002/jcb.25897. Epub 2017 Mar 15. Review.

PMID:
28106283

Supplemental Content

Loading ...
Support Center